The Transformation of AML Therapy: Updates in Front-Line and Maintenance Therapies and Considerations for Older Patients
This activity will focus on many novel agents used in the treatment of AML, including targeted agents and the role of hypomethylating agents in maintenance therapy.
BTK Inhibitors in B-Cell Malignancies: Implementing Digital Technology to Optimize Outcomes
This activity will review the clinical data for the use of BTK inhibitors in the management of B-cell malignancies. Potential medication-associated adverse effects will be discussed, with an emphasis on cardiac events.
The Promising Role of Targeted Therapies for the Treatment of X-Linked Hypophosphatemia and Tumor-Induced Osteomalacia: Key Considerations for Pharmacists
This activity will review evolving research in treatment and management of these conditions, and the role of pharmacists in significantly contributing to improving quality of life and reducing health care costs for patients with TIO and XLH.
Continuous Glucose Monitoring: Understanding the Pharmacist's Role in Patient Education and Improving Outcomes in Diabetes Management
Two pharmacist experts in diabetes management will discuss their clinical experience with CGM technology, explain how community pharmacists can help patients seeking information about CGM, and offer considerations for the next frontiers for CGM technology.